Each of these NE-induced deleterious effects was ameliorated by administration of an NE inhibitor; therefore, controlling NE activity constitutes an attractive therapeutic technique for preventing lung injury in pneumococcal pneumonia. The gene discussed is ELANE; the disease is pneumococcal pneumonia.